Previous 10 | Next 10 |
Lightning 12 and Separator 12 Now Indicated for Treatment of PE Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for expanded indication of the latest iteration of the ...
Penumbra has had a better than expected 3rd quarter, and is well positioned to capitalise on a rebound in vascular and neurological procedures. The company has been a pioneer and advocate of mechanical thrombectomy in ischemic stroke patients, helping improve patient outcomes. The...
Beyond Meat (BYND) -23% on Q3 earnings release.InnSuites Hospitality (IHT) -20%.Jumia Technologies (JMIA) -19% on Q3 earnings release.Aurora Cannabis (ACB) -13%.Applied UV (AUVI) -13%.GasLog Partners (GLOP) -13% on Q3 earnings release.Waitr Holdings (WTRH) -...
Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism PR Newswire ALAMEDA, Calif., Nov. 10, 2020 ALAMEDA, Calif. , Nov. 10, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company foc...
Penumbra, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum Penumbra, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum PR Newswire ALAMEDA, Calif., Nov. 6, 2020 ALAMEDA, Calif. , Nov. 6, 2020 ...
Shares of Penumbra (NYSE: PEN) were popping on Thursday, with the stock up 10.6% as of 12:15 p.m. EDT. The medical device maker announced better-than-expected third-quarter results after the market closed on Wednesday. Penumbra reported Q3 revenue of $151.1 million, up 8.3% year...
Gainers: vTv Therapeutics (VTVT) +22%, Forte Biosciences (FBRX) +20%, Penumbra (PEN) +14%, Cellect Biotechnology (APOP) +10%, Inari Medical (NARI) +10%.Losers: Tricida (TCDA) -52%, Cancer Genetics (CGIX) -34%., Constellation Pharmaceutica...
Image source: The Motley Fool. Penumbra Inc (NYSE: PEN) Q3 2020 Earnings Call Oct 28, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Penumbra Inc (PEN) Q3 2020 Earnings Call Transcript
Penumbra, Inc. (PEN) Q3 2020 Results Earnings Conference Call October 28, 2020, 04:30 PM ET Company Participants Jee Hamlyn-Harris - Investor Relations Adam Elsesser - President, Chairman and Chief Executive Officer Maggie Yuen - Chief Financial Officer Conference Call Participants Larry Bieg...
Penumbra (PEN): Q3 Non-GAAP EPS of $0.06 beats by $0.14; GAAP EPS of -$0.24 misses by $0.14.Revenue of $151.08M (+8.3% Y/Y) beats by $26.13M.Shares +3.13%.Press Release For further details see: Penumbra EPS beats by $0.14, beats on revenue
News, Short Squeeze, Breakout and More Instantly...
2024-07-13 17:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-03 18:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 PR Newswire ALAMEDA, Calif. , July 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial resu...